Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease
Section snippets
Acknowledgements
We acknowledge support of the Swedish Medical Research Council, the Loo and Hans Ostermans' Foundation, the Gamla Tjännarinor Foundation, and the Greta Lindenau-Hansells Foundation.
References (22)
- et al.
Topography of the quantitative Electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia
Psych. Res.-Neuroimag.
(1991) - et al.
Tacrine in Alzheimer's disease
Lancet
(1991) - et al.
Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography
Neurobiol. Aging
(1992) - et al.
Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristics, visual EEG and CCT
Electroenceph. clin. Neurophysiol.
(1994) - et al.
Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: neuropsychological and computerized electroencephalographic study
Clin. Neuropharmacol.
(1983) - et al.
Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy
Acta Neurol. Scand. Suppl.
(1993) - et al.
Nucleus basalis and thalamic control of neocortical activity in the freely moving rat
J. Neurosci.
(1988) - et al.
A double-blind, placebo controlled multicenter study of tacrine for Alzheimer's disease
New Engl. J. Med.
(1992) Equivalent EEG sources determined by FFT approximation in healthy subjects, schizophrenic and depressive patients
Brain Topography
(1992)- et al.
A Controlled trial of tacrine in Alzheimer's disease
J. Am. Med. Assoc.
(1992)
Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment
Dementia
(1996)
Cited by (0)
Copyright © 1998 Elsevier Science Ireland Ltd. All rights reserved.